Middleman AB, Robertson LM, Young C,
DuRant RH, Emans SJ. "Predictors of adolescent compliance with
the hepatitis B vaccination series." Journal of Adolescent
Health. 1999; 25:323-327. Read
abstract
Middleman AB, Kozinetz CA, Robertson
LM, DuRant RH, Emans SJ. "The effect of late doses on the
achievement of seroprotection and antibody titer levels with
hepatitis B immunization among adolescents." Pediatrics.
2001; 107:1065-1069. Read
abstract or
full text
Schmidt RM, Middleman AB. "The
importance of hepatitis B vaccination among adolescents."
Journal of Adolescent Health.2001; 29:217-222.
Read
abstract
Guajardo AD, Middleman AB, Sansaricq
KM. "School nurses identify barriers and solutions to improve
the success of a school-based immunization program." Journal
of School Health. 2002; 72:128-130.
Middleman AB, Guajardo AD, Sansaricq
KM. "School-based hepatitis B immunization programs: parental
knowledge and attitudes." Journal of School Health. 2002;
72(8):348-351.
Middleman AB. "Race/ethnicity and
gender disparities in the utilization of a school-based
hepatitis B immunization initiative." Journal of Adolescent
Health. 2004; 34(5):414-419. Read
abstract
Tung CS, Middleman AB. "An evaluation
of school-level factors used in a Successful school-based
hepatitis B immunization initiative." Journal of Adolescent
Health. 2005; 37:61-68. Read
abstract
Middleman AB, Rosenthal SL, Rickert
VI, Neinstein L, Fishbein DB, D’Angelo L. "Adolescent
immunizations: position paper of the Society for Adolescent
Medicine." Journal of Adolescent Health. 2006;
38:321-327. Read
abstract
Rupp R. Rosenthal SL. Middleman AB.
"Vaccination: an opportunity to enhance early adolescent
preventative services." Journal of Adolescent Health.
2006; 39:461-4. Read
abstract
Friedman LS, Kahn J, Middleman AB,
Rosenthal S, Zimet G, Society for Adolescent Medicine. "Human
Papillomavirus(HPV) Vaccine: position statement of the Society
for Adolescent Medicine." Journal of Adolescent Health.
2006; 39:620.
Middleman AB. "Immunization update:
pertussis, meningoccocus and human papillomavirus."
Adolescent Medicine Clinics. 2006;17:547-63. Read
abstract
Middleman AB. “New adolescent
vaccination recommendations and how to make them “stick”.” Curr
Opin Pediatr 2007;19:411-416
Middleman AB. “Adolescent
immunizations: policies to provide a shot in the arm for
adolescents.” J Adolesc Health 200; 41:109-118
Kharbanda EO, Maehr J, Middleman AB,
Rickert VI, Zimet GL. 'Influenza vaccine: a position statement
of the society for adolescent medicine.” J Adolesc Health
2007; 41: 216-217
Lindley MC, Boyer-Chu L, Fishbein DB,
Kolasa M, Middleman AB, Wilson T, Wolicki J, Wooley S; Working
Group on the role of Schools in Delivery of Adolescent
Vaccination. “ The role of schools in strengthening delivery of
new adolescent vaccinations.” Pediatrics 2008;121:S46-S54
Healy CM, Butler KM, Smith EO, Hensey
OP, Bate T, Moloney A, McMahon P, Cosgrove J, Cafferkey MT. "Serogroup
influence on presentation, course and outcome of invasive
meningococcal disease in children in the Republic of Ireland."
Clinical Infectious Diseases. 1995-2000; 2002;34:1323-30.
Read
abstract or
full text
Balding J, Healy CM, Livingstone WJ,
White B, Mynett-Johnson L, Cafferkey MT, Smith OP. "Genomic
polymorphic profiles in an Irish population with invasive
meningococcal disease: Is it possible to predict severity and
outcome of disease?" Genes Immun 2003;4:533-40.
Healy CM, Baker CJ. "The Future of
Meningococcal Vaccines." The Pediatric Infectious Diseases
Journal. 2005;24:175-176.
Committee on Infectious Diseases,
American Academy of Pediatrics (Baker CJ, lead author).
"Prevention and control of meningococcal disease:
recommendations for use of meningococcal vaccines in pediatric
patients." Pediatrics. 2005;116:496-505. Read
abstract or
full text
Hepatitis A vaccine
Baker CJ. “Another success for
hepatitis A vaccine.” N Engl J Med 2007; 357: 1757-1759
Baker CJ, Rench MA, Kasper DL. "The
response of women whose infants have had invasive group B
streptococcal infection to type III polysaccharide." New
England Journal of Medicine. 322:1857, 1990.
Kasper DL, Paoletti LC, Wessels MR,
Guttormsen H-K, Carey VJ, Jennings HJ, Baker CJ. "Immune
response to type III group B streptococcal
polysaccharide-tetanus toxoid conjugate vaccine." Journal of
Clinical Investigation. 98:2308-14, 1996. Read
abstract or
full text (pdf)
Baker CJ, Paoletti LC, Wessels MR,
Guttormsen H-K, Rench MA, Hickman ME, Kasper DL. "Safety and
immunogenicity of capsular polysaccharide-tetanus toxoid
conjugate vaccines for group B streptococcal types Ia and Ib."
Journal of Infectious Diseases. 1999;179:142-150. Read
abstract or
full text
Baker CJ, Paoletti LC, Rench MA,
Guttormsen H-K, Carey VJ, Hickman ME, Kasper DL. "Use of
capsular polysaccharide-tetanus toxoid conjugate vaccine for
type II group B Streptococcus in healthy women." Journal of
Infectious Diseases. 2000;182:1129-38. Read
abstract or
full text
Paoletti LC, Rench MA, Kasper DL,
Molrine D, Ambrosino D, Baker CJ. "Effects of alum adjuvant or a
booster dose on immunogenicity during clinical trials of group B
streptococcal type III conjugate vaccines." Infection and
immunity. 2001;69:6696-6701. Read
abstract
Baker CJ, Rench MA, McInnes P.
"Immunization of pregnant women with group B streptococcal type
III capsular polysaccharide-tetanus toxoid conjugate vaccine."
Vaccine. 2003;21:3468-3472. Read
abstract
Baker CJ, Edwards MS. "Group B
streptococcal conjugate vaccines." Archives of Disease in
Childhood. 2003;88:375-378. Read
abstract
Baker CJ, Rench MA, Fernandez M,
Paoletti LC, Kasper DL, Edwards MS. "Safety and immunogenicity
of a bivalent group B streptococcal conjugate vaccine for
serotypes II and III." Journal of Infectious Diseases.
2003;188:66-73.
Read
abstract or
full text
Baker CJ, Paoletti LC, Rench MA,
Guttormsen H-K, Edwards MS, Kasper DL. "Immune response of
healthy women to two different type V group B streptococcal
capsular polysaccharide-protein conjugate vaccines." Journal
of Infectious Diseases. 2004;189:1103-1112. Read
abstract or
full text
Palazzi DL, Rench MA, Edwards MS,
Baker CJ. "Use of type V group B streptococcal vaccine in adults
65-85 years old." Journal of Infectious Diseases.
2004; 190:558-664. Read
abstract or
full text
Baker CJ, Rench MA, Paoletti LC,
Edwards MS. "Dose-response to type V group B streptococcal
polysaccharide-tetanus toxoid conjugate vaccine in healthy
adults." Vaccine. 2007; 25:55-63. Read
abstract
Pannaraj PS, Kelly JK, Madoff LC,
Rench MA, Lachenauer CS, Edwards MS, Baker CJ. “Group B
Streptococcus bacteremia elicits beta C protein-specific IgM and
IgG in humans.” J Infect Dis 2007; 195: 353-356
Pannaraj PS, Kelly JK, Rench MA,
Madoff LC, Edwards MS, Baker CJ. “ Alpha C protein-specific
immunity in humans with group B streptococcal colonization and
invasive disease.” Vaccine 2008; 26:502-508
Pertussis
Healy CM, Munoz FM, Rench MA, Halasa
NB, Edwards KE, Baker CJ. "Prevalence of pertussis antibodies in
maternal, cord and infant sera." Journal of Infectious
Diseases. 2004;190:335-40. Read
abstract or
full text
Healy CM, Rench MA, Edwards KE, Baker
CJ. "Pertussis serostatus among neonates born to Hispanic
women." Clinical Infectious Diseases. 2006;42:1439-1442.
Read
abstract or
full text
General maternal immunization
Healy CM, Baker CJ. "Prospects for
prevention of childhood infections by maternal immunization."
Current Opinion in Infectious Diseases. 2006;19:271-276. Read
abstract
Boom JA, Nelson CS, Laufman LE, Kohrt
AE, Kozinetz CA. “Improvement in provider immunization knowledge
and behaviors following a peer education intervention.” Clin
Pediatr (Phila) 2007;46:706-717
Franzini L, Boom J, Nelson C. “Cost-effectiveness
analysis of a practice-based immunization education
intervention.”Ambul Pediatr 2007; 7:167-175
